New herbal business conference aims to support emerging botanical brands by providing a venue to learn about formulation, GMPs, sustainable sourcing, claim substantiation, federal regulation enforcement, choosing a contract lab, and more.
Can the First Amendment shield a publisher of supposedly independent product reviews if it has secretly rigged the ratings in favor of one company in exchange for compensation? According to a recent decision, this speech qualifies as commercial speech.
The White House Office of Management and Budget pulled six FDA guidances and rules from its review, including the proposal "Cannabidiol Enforcement Policy; Draft Guidance for Industry" — handing the CBD industry yet another setback.
Federal Trade Commission Chairman Joseph Simons announced his resignation yesterday, which begins the process of filling slots at the commission with Biden Administration appointees. A reformed FTC is likely to take a stronger line on consumer protection,...